As we look ahead to 2026, labs are preparing for new challenges and opportunities. What would you gift your lab to support a stronger, more efficient future? Cast your vote in this month’s MLO poll.
The World Health Organization (WHO) has published a statement regarding vaccines and autism. Their position comes from an analysis from The Global Advisory Committee on Vaccine Safety (GACVS).
The Centers for Medicare & Medicaid Services (CMS) has expired several Clinical Laboratory Improvement Amendments of 1988 (CLIA) memos and guidance recently. The following memos are no longer in practice.
Roche has received FDA approval for additional indications of its PATHWAY anti-HER2/neu (4B5) Rabbit Monoclonal Primary Antibody and VENTANA HER2 Dual ISH DNA Probe Cocktail tests, enabling better identification of HER2-positive metastatic breast cancer patients for treatment with ENHERTU.
PathAI's AIM-MASH AI Assist has received FDA qualification through the DDT Biomarker Qualification Program, marking a significant advancement in AI-assisted histopathology for MASH clinical trials, streamlining drug development processes.
